Breaking AI & Tech News Analyzed

FDA Clearance Marks a Milestone for BioticsAI's Ultrasound AI CopilotRobhy Bustami, co‑founder and CEO of BioticsAI, announced that the company obtained FDA approval in January 2026, unlocking the ability to launch its fetal‑abnormality detection system in clinical settings.From Scrappy Prototype to Regulatory SuccessThe team built a functional prototype for under $100,000, an unusually low cost for a medical‑device startup. That early version helped them win TechCrunch Startup Battlefield 2023, providing visibility and credibility that accelerated investor interest.Prototype cost: $100kTechCrunch Battlefield win: 2023FDA approval received: January 2026Financial and Timeline Metrics Behind the ClearanceWhile the article does not disclose full fundraising numbers, the rapid prototype and battlefield win suggest a capital‑efficient path. Early regulatory engagement—pre‑submission meetings with the FDA— reduced uncertainty and compressed the typical multi‑year approval timeline.Early regulator meetings: pre‑submission phaseTypical FDA device timeline: 18‑36 months (compressed by early alignment)Why FDA Approval Shifts the AI‑Healthcare LandscapeGaining clearance validates the technical approach and signals to hospitals that the product meets rigorous safety standards. It also demonstrates a repeatable model for other AI‑driven diagnostics, encouraging more founders to embed regulatory strategy from day one.Creates a trusted entry point for hospital adoptionSets a precedent for AI‑based fetal imaging toolsHighlights the need for cross‑functional teams (engineers, clinicians, regulators)Looking Ahead: Expansion Beyond ObstetricsWith the FDA hurdle cleared, BioticsAI plans to deploy its technology across obstetric units and later broaden into other reproductive‑health applications. The founder emphasizes continued data collection, partnership growth, and potential international regulatory filings as the next growth levers.Phase 1: Hospital rollout in obstetrics (2026‑2027)Phase 2: Expansion into broader reproductive health diagnostics (2028+)Long‑term goal: Global market penetration with localized regulatory approvals

The Politicization of Science Donald Trump’s war on science has been vicious and hugely damaging, but it is worth noting that he has lost some of its biggest battles. Last year, Mr Trump demanded that US federal scientific and medical research funding be cut by about half. But the budget Congress passed in February actually delivered a slight increase in overall funding – although specific Trump targets such as the Centers for Disease Control and Prevention were cut. Resistance from Congress He also continues to chip away at science in other ways such as dismissing the board overseeing the National Science Foundation this week. Maga’s attacks on science have been nakedly political. Its defeats have been politics of a different sort, showing that the bipartisan pro-science consensus is still intact, and for the moment has the power to hold Mr Trump in check. A Global Trend What is happening in the US is not unique. Wherever rightwing populists triumph, science is likely to suffer. Jair Bolsonaro’s rule in Brazil saw him attack scientists and cut environmental funding. In India, Narendra Modi’s Hindu nationalist government purged the theory of evolution from school textbooks. In Britain, Reform UK has already attempted local government cuts, targeting net zero spending. The Changing Role of Scientists Scientists have tended to avoid party politics for a specific reason. Historians identify an implicit scientific social contract that emerged in western states after the second world war, which established the state as the main funder of research, but in theory discouraged direct political interference by government. Many scientists believe that engaging in politics endangers this compact: if scientists don’t bother politics, it won’t bother them. A New Era for Science and Politics Scientists are no longer just defending funding. They are defending the idea that science should be independent of politics. What scientists gain by organising protests, speaking to the public through their academies and now running for office is a better understanding of the changing public sphere that they are part of. The public may gain an ally against rightwing populism – and a deeper, more serious engagement with the scientific challenges facing society. Mr Trump set out to tame scientists. He may have politicised them instead.

Lead: The Evening's High‑Stakes DerbyAt 8 pm BST the City Ground becomes the stage for a rare showdown between two neighbouring English clubs in a European semi‑final. The atmosphere is described as "absolutely colossal" as fans anticipate a match that blends cup‑final intensity with continental ambition.Event Details: Form, History, and Kick‑offKick‑off: 20:00 BSTNottingham Forest: 16th in the Premier League, recent surge in form after a relegation‑battle narrative.Aston Villa: 5th in the Premier League, historically the stronger side but currently struggling with spotty performances.Historical backdrop: Forest lifted the UEFA Cup in 1979 and 1980; Villa won it in 1982, adding a nostalgic layer to the encounter.Data Snapshot: League Positions and Recent ResultsWhile no specific match‑day statistics are available yet, the league standings provide a clear contrast:Forest: 16th place, points tally hovering just above the relegation zone.Villa: 5th place, within striking distance of a top‑four finish.These positions suggest a classic underdog versus favorite dynamic, amplified by recent form trends.Impact: Regional Pride and European AmbitionsThe fixture is more than a semi‑final; it is a clash of regional identity. Success for either side could:Boost the winning club’s European credibility and attract higher‑profile players.Reignite local rivalries, influencing ticket sales and fan engagement across the Midlands.Potentially affect Premier League momentum, with a win offering a psychological edge in the domestic race.Looking Ahead: Scenarios for the Semi‑FinalAnalysts foresee three primary outcomes:Forest edge a narrow win: A 1‑0 or 2‑0 advantage would give them a realistic chance to reach the final, leveraging home support.Villa dominate: A two‑goal margin could see them control the tie, making the second leg a formality.Dead‑heat: A draw would set up a tense return leg at Villa Park, where the higher‑ranked side might rely on their league quality.Regardless of the result, the tie promises to shape the narrative of English clubs in Europe for the remainder of the season.

The Journey from Prototype to ClearanceBuilding a medical device is fundamentally different from standard software development. This week on Build Mode, host Isabelle Johannessen sat down with Robhy Bustami, co-founder and CEO of BioticsAI, to discuss the arduous path from a $100,000 prototype to FDA clearance. Bustami, a Startup Battlefield winner, detailed how his team is building an AI copilot for ultrasound designed to detect fetal abnormalities. The conversation revealed that the traditional startup mantra of 'move fast and break things' is obsolete in the medical sector, replaced by a necessity for extreme precision and coordination.Market Validation and Resource AllocationThe episode provides a strategic look at the 'data' driving medtech success. BioticsAI's recognition as a Startup Battlefield winner serves as a key validation of their technology's potential. However, Bustami emphasized that the primary data point for founders is not just market traction, but the successful navigation of complex regulatory pathways. This requires a significant reallocation of resources—shifting focus from rapid feature deployment to ensuring safety, reliability, and compliance with FDA standards.Shifting the MedTech CultureThe core impact of this discussion lies in the cultural shift it highlights for the industry. As timelines for FDA approval remain uncertain, the ability to maintain team morale and investor confidence becomes a critical operational metric. Bustami noted that building in a regulated industry requires a foundation of trust rather than speed. This signals a broader trend where medtech startups must balance the pressure of hyper-growth with the ethical and legal responsibilities of patient safety.The Future of AI in Healthcare RegulationLooking ahead, the medtech landscape will likely see a consolidation of companies that prioritize long-term compliance over short-term hype. As more AI copilots enter the market, the winners will be those founders who master the art of 'slow and steady' innovation. The next wave of medical breakthroughs will depend not just on algorithmic superiority, but on the ability to build sustainable organizations capable of weathering the regulatory storm.

The Challenges of FDA Approval Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. Lessons from BioticsAI This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building an AI copilot for ultrasound to help detect fetal abnormalities. From a $100,000 prototype to FDA clearance, Bustami shares what it actually takes to build in one of the most regulated industries in the world. Building a Medtech Startup In this episode, they break down what it really looks like to build a medtech startup, including where you can’t “move fast and break things” and that every milestone takes time, coordination, and trust. Key Takeaways Team motivation is crucial during the long FDA approval process Finding the right investors is essential for medtech startups Adaptability is key when dealing with uncertain timelines Future Outlook As the medtech industry continues to evolve, startups like BioticsAI will play a critical role in shaping the future of healthcare technology. With the right approach and mindset, these companies can overcome the challenges of FDA approval and make a lasting impact.

Blockx’s Historic Run in the Spanish CapitalBelgian rising star Alexander Blockx has delivered a performance of a lifetime at the Madrid Open, defeating defending champion Casper Ruud 6-4, 6-4 to secure a spot in the semi-finals. The 21-year-old, ranked 69th, has defied all odds to reach the last four, marking his best result on clay to date.Scoreline: Blockx defeated Ruud in straight sets (6-4, 6-4).Ranking Milestone: He is the fourth lowest-ranked player to reach the men's semi-finals in Madrid.Performance: He is 4-2 against top 20 opponents this month, with all four wins coming in the last three weeks.“To be honest, I’m just happy with being here,” Blockx said. “Semi-finals is something I wouldn’t have even dreamed of to begin with.” The conditions in Madrid, characterized by slow clay and high altitude, have seemingly suited Blockx’s aggressive style, allowing him time to settle and dictate points.Ruud’s Historic Fall from GraceCasper Ruud’s loss marks a significant downturn in the Norwegian’s career trajectory. The defeat sees Ruud exit the top 20 for the first time since May 2021, signaling a potential shift in the hierarchy of men's clay-court tennis. Ruud, who had been the defending champion, struggled to find rhythm against the relentless pressure of Blockx’s game.The WTA Final and Alcaraz’s AbsenceOn the women's side, 19-year-old Mirra Andreeva battled nerves to defeat Hailey Baptiste 6-4, 7-6 (8), securing her place in the Madrid final. Andreeva, who turned 19 on Wednesday, boasts an impressive 12-1 record on clay this season. Her victory comes after a dramatic second set tie-break where she saved three set points to overcome the American.Simultaneously, the tournament was dealt a blow with the withdrawal of world No. 2 Carlos Alcaraz. The Spanish superstar is sidelined due to a right wrist injury, a setback that will prevent him from defending his French Open title in three weeks. Alcaraz was present in the stands, however, cheering on his younger brother Jaime in an under-16 tournament.Future Outlook: A New Era DawningThe Madrid Open is rapidly becoming a proving ground for the next generation of tennis talent. With Blockx and Andreeva reaching deep stages, the sport is witnessing a generational transition. For Blockx, a semi-final appearance at a Masters 1000 event is a statement of intent, suggesting he could be a major force to be reckoned with on clay in the coming years. For Ruud, the focus will shift to recovery and recalibrating his game to reclaim his position among the elite.

John Higgins fought back from a 3‑1 deficit to level the World Snooker Championship semi‑final 4‑4 against Shaun Murphy, setting up a decisive final session.Higgins Forces a Deadlock in a Nail‑Biting Semi‑FinalThe four‑time champion, playing his 100th match at the Crucible, clawed back after Murphy surged ahead with a 110‑1 opening frame and a century break in the fourth. Higgins won three of the next four frames to bring the score to an even 4‑4 heading into the second session.Frame‑By‑Frame Scoreline Highlights the SwingFrame 1: Murphy 110‑1 (breaks 42, 68)Frame 2: Higgins 65‑27Frame 3: Murphy 69Frame 4: Murphy century (lead 3‑1)Frames 5‑8: Higgins wins three, Murphy one (score 4‑4)Implications for the Championship Final and Legacy BattlesThe tie revives the 2009 final showdown between the two veterans and puts both players on a collision course with the reigning champion, Zhao Xintong, who was defeated by Higgins in the quarter‑finals. A win for either could mark a rare second world title for Murphy or a triumphant return to the final for Higgins after a 17‑year gap.What the Decider Could Mean for Both VeteransShould Higgins prevail, he would become the oldest finalist in over a decade, reinforcing his status as a snooker great. Conversely, a Murphy victory would end his 21‑year wait for a second world crown, reshaping the sport’s contemporary hierarchy. The final session promises high drama, with momentum now firmly in Higgins’ hands but Murphy still very much in contention.

Manchester United's Transfer Strategy Manchester United is actively pursuing West Ham's left-back El Hadji Malick Diouf to provide competition for Luke Shaw. Diouf, a 21-year-old Senegal international, joined West Ham for €22m (£19m) from Slavia Prague and has become a crucial player for the team. Diouf's Potential and Stats Diouf's defensive skills have improved, and his crossing ability has added to his attacking threat. West Ham is aware of United's interest but may listen to offers depending on their relegation battle status. The Mainoo Contract Extension In a separate move, Kobbie Mainoo has signed a new contract with Manchester United until June 2031, earning a basic salary of about £120,000 a week. Mainoo, 21, has impressed since his first league start and is seen as a potential star by the club's director of football, Jason Wilcox. United's Midfield Priorities Manchester United is initially focusing on strengthening their midfield, with targets including Atalanta's Éderson, Newcastle's Sandro Tonali, and Nottingham Forest's Elliot Anderson. The club may also consider a left-winger or a defensive player to compete with Shaw. Financial Context West Ham's financial position, marked by losses of £104.2m for the year ending 31 May 2025, might influence their willingness to sell players this summer.

Supreme Court Decision Reshapes Voting Rights LandscapeThe United States Supreme Court has voided a key provision of a landmark civil rights law by ruling that the electoral map of Louisiana had been drawn up unconstitutionally to create two Black-majority districts. The decision represents a major reinterpretation of the landmark Voting Rights Act of 1965 – in particular, its provision designed to protect minority voters from having their political power diluted.Wednesday's Supreme Court ruling is seen as a major win for Louisiana Republicans and President Donald Trump's administration and is expected to make it harder for minorities to challenge electoral maps as racially discriminatory under the 1965 law. It is unclear how much of that provision – Section 2 of the act – remains in force following this decision.The Louisiana Redistricting RulingThe court held that a map that created two Black-majority congressional districts in Louisiana was unconstitutional. The 6-3 ruling by justices blocks an electoral map that had given Louisiana a second Black-majority US congressional district.The court's conservative majority found that the Louisiana district represented by Democrat Cleo Fields relied too heavily on race. Chief Justice John Roberts described the 6th Congressional District as a "snake" that stretches more than 320km (200 miles) to link parts of Shreveport, Alexandria, Lafayette and Baton Rouge.The ruling was authored by Justice Samuel Alito and joined by his five fellow conservative justices. The dissenting justices are liberals."That map is an unconstitutional gerrymander," Alito wrote on behalf of the six conservatives.Understanding the Voting Rights ActThe Voting Rights Act was a piece of follow-up legislation to the Civil Rights Act, signed into law by President Lyndon B Johnson in 1964. It bans discrimination on the basis of race, colour, religion, sex or national origin.The 1965 law primarily ended common discriminatory practices against Black voters that were prevalent in many states, including literacy tests, that were designed to prevent them from voting.Section 2 of the act prohibits voting practices or procedures that discriminate on the basis of race, colour or membership of a language-minority group. The section has long been understood to bar electoral maps that dilute the voting strength of minority communities, even when there is no direct evidence of racist intent.How the Court Weakened the Voting Rights ActSection 2 of the act was amended by Congress in 1982 to prohibit electoral maps that would result in undermining the clout of minority voters, even without direct proof of racist intent.For more than four decades, plaintiffs could win a Section 2 claim by showing that a voting map had a racially discriminatory impact under this legal standard, known as the "results test".The Supreme Court's ruling on Wednesday, however, has in effect applied an "intent test" to Section 2, experts said. In the ruling, Alito wrote that the focus of Section 2 must now be to enforce the US Constitution's prohibition on intentional racial discrimination under its 15th Amendment.Interpreting Section 2 to "outlaw a map solely because it fails to provide a sufficient number of majority-minority districts would create a right that the amendment does not protect", Alito concluded.Political Power Shifts in CongressThe effect of the ruling may be felt more strongly in 2028 because most filing deadlines for this year's congressional races have already passed. Louisiana, though, may have to redraw its congressional districts now to comply with the decision.Republicans currently hold 217 seats in the House while Democrats hold 212. There is one independent and five vacancies in the House. In the Senate, Republicans hold 53 seats and Democrats hold 45. Two independents caucus with the Democrats.The state has primary elections set for May 16. Louisiana Governor Jeff Landry told Republican candidates for the House of Representatives that he planned to suspend next month's primary elections to allow state lawmakers time to approve a new congressional map.Erosion of Civil Rights ProtectionsReactions to the ruling have been sharply divided along political lines."I love it," Trump told reporters after hearing of the decision, adding that he believes Republican-led states will now want to reconfigure their voting maps. In a social media post, Trump praised Alito as "brilliant" and called the ruling "a BIG WIN for Equal Protection under the Law, as it returns the Voting Rights Act to its Original Intent, which was to protect against intentional Racial Discrimination".Former President Barack Obama, a Democrat, warned that the ruling will free state legislatures to reconfigure electoral districts to "systematically dilute and weaken the voting power of racial minorities – so long as they do it under the guise of 'partisanship' rather than explicit 'racial bias'"."This is a devastating and profound step backwards for American Democracy," Democratic Senator Raphael Warnock wrote on social media.Justice Elena Kagan, in a dissent joined by the two other liberal justices on the Supreme Court, said the ruling rendered the Voting Rights Act "all but a dead letter" and predicted "grave" consequences.Redistricting Battles Ahead of 2026 MidtermsWith November's congressional elections looming, the court's decision could prompt Republican-led states to seek to redraw electoral maps to weaken US House seats considered safely Democratic.The ruling comes during a wider battle over congressional redistricting before midterm elections in November. The Congressional Black Caucus, a group of African American US lawmakers, condemned the ruling."Without the protections of the VRA [Voting Rights Act], Republicans now have the ability to move forward with a nationwide scheme to rig congressional maps in their favor – to manufacture more districts for themselves by eliminating majority-Black districts, while stripping away the ability to challenge those racist, anti-Black maps in court," it said in a statement.Warnock, a member of the caucus, said the ruling gutted the protections that civil rights champion Martin Luther King Jr "marched for [and] the protections made possible by civil rights protesters who spilled blood in pursuit of a more perfect union".